The impact of new technologies on drug design
1Norman Consulting, Burnham, UK.
Abstract:
The Cutting Edge Approaches to Drug Design symposium, held March 13, 2001, in London, U.K., was organized by the Royal Society of Chemistry's Molecular Modelling Group and the Structural Biology Group of the Biochemical Society. The symposium was aimed primarily at medicinal chemists keen to discover how cutting edge methods can accelerate drug design. The talks were aimed at the nonspecialist, and topics included target finding, virtual screening, informatics in lead optimization and in silico pharmacokinetic profiling. Several examples demonstrated the power of these methods.
Related Concept Videos
Drug Discovery: Overview
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Pharmacogenomics: Identification of New Drug Targets


